Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt New manufacturing sites and new formulation approved for COVID-19 vaccine from BioNTech/Pfizer 18 oktober 2021NewsHumanCOVID-19Vaccines First-in-class medicine to treat aggressive form of breast cancer 15 oktober 2021NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 oktober 2021NewsHumanMedicinesReferrals EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 oktober 2021NewsHumanCOVID-19Medicines EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 oktober 2021NewsHumanCOVID-19Vaccines A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 oktober 2021NewsHumanCOVID-19MedicinesVaccines EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 oktober 2021NewsHumanCOVID-19Paediatrics Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 oktober 2021NewsVeterinaryMedicines Highlights of Management Board – October 2021 meeting 8 oktober 2021NewsCorporate Additional manufacturing site for COVID-19 Vaccine Janssen 7 oktober 2021NewsHumanCOVID-19 1 … 56 57 58 59 60 Page 60 of 383 61 62 63 64 … 383
New manufacturing sites and new formulation approved for COVID-19 vaccine from BioNTech/Pfizer 18 oktober 2021NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 oktober 2021NewsHumanMedicinesReferrals
EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 oktober 2021NewsHumanCOVID-19Medicines
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 oktober 2021NewsHumanCOVID-19Vaccines
A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 oktober 2021NewsHumanCOVID-19MedicinesVaccines
EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 oktober 2021NewsHumanCOVID-19Paediatrics
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 oktober 2021NewsVeterinaryMedicines